Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Lyell Immunopharma
LYEL
$317M
| $1.88M | ﹤0.01% |
64,882
+911
| +1% | +$43.4K |
|
2727
Nektar Therapeutics
NKTR
$2.39B
| $1.84M | ﹤0.01% |
99,182
+23,961
| +32% | +$505K |
|
2728
Target Hospitality
TH
$1.51B
| $1.84M | ﹤0.01% |
211,021
-20,945
| -9% | -$219K |
|
2729
ZTO Express
ZTO
$18.3B
| $1.83M | ﹤0.01% |
+88,237
| New | +$1.93M |
|
2730
Universal Technical Institute
UTI
$2.16B
| $1.83M | ﹤0.01% |
116,034
+4,963
| +4% | +$74.3K |
|
2731
Allient
ALNT
$1.49B
| $1.82M | ﹤0.01% |
71,927
+6,518
| +10% | +$187K |
|
2732
RLX Technology
RLX
$2.47B
| $1.81M | ﹤0.01% |
986,306
-8,260
| -0.8% | -$15.6K |
|
2733
Stratasys
SSYS
$679M
| $1.81M | ﹤0.01% |
215,599
-63,626
| -23% | -$605K |
|
2734
TTEC Holdings
TTEC
$121M
| $1.81M | ﹤0.01% |
307,315
-23,059
| -7% | -$169K |
|
2735
Johnson Outdoors
JOUT
$491M
| $1.79M | ﹤0.01% |
51,243
+2,662
| +5% | +$103K |
|
2736
Granite Ridge Resources
GRNT
$627M
| $1.79M | ﹤0.01% |
282,959
+42,035
| +17% | +$271K |
|
2737
Liberty Latin America Class A
LILA
$1.64B
| $1.79M | ﹤0.01% |
274,161
-193,248
| -41% | -$1.08M |
|
|
THRD
2738
DELISTED
Third Harmonic Bio
THRD
| $1.79M | ﹤0.01% |
137,462
+6,857
| +5% | +$84.8K |
|
2739
Harrow
HROW
$1.45B
| $1.78M | ﹤0.01% |
85,027
+3,198
| +4% | +$47.8K |
|
|
MTAL
2740
DELISTED
Metals Acquisition
MTAL
| $1.78M | ﹤0.01% |
+129,738
| New | +$1.75M |
|
2741
Dianthus Therapeutics
DNTH
$5.84B
| $1.77M | ﹤0.01% |
+68,567
| New | +$1.65M |
|
2742
Telos
TLS
$332M
| $1.77M | ﹤0.01% |
440,945
+162,059
| +58% | +$615K |
|
2743
Miller Industries
MLR
$573M
| $1.74M | ﹤0.01% |
31,708
+1,414
| +5% | +$77.7K |
|
|
FLIC
2744
DELISTED
First of Long Island Corp
FLIC
| $1.73M | ﹤0.01% |
172,968
+3,735
| +2% | +$37.9K |
|
2745
Precigen
PGEN
$2.24B
| $1.73M | ﹤0.01% |
1,095,383
+26,856
| +3% | +$39K |
|
2746
IMAX
IMAX
$2.62B
| $1.73M | ﹤0.01% |
103,201
-21,473
| -17% | -$355K |
|
2747
Microvision
MVIS
$93.2M
| $1.73M | ﹤0.01% |
1,631,875
+242,835
| +17% | +$320K |
|
|
TSVT
2748
DELISTED
2seventy bio
TSVT
| $1.73M | ﹤0.01% |
449,278
-165,247
| -27% | -$745K |
|
2749
Solid Power
SLDP
$463M
| $1.73M | ﹤0.01% |
1,048,084
+77,705
| +8% | +$134K |
|
2750
Kiniksa Pharmaceuticals
KNSA
$5.8B
| $1.73M | ﹤0.01% |
92,408
+8,253
| +10% | +$155K |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.